Substance
ID:73269
Names and Identifiers
IUPAC Traditional name
glimepiride
IUPAC name
3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide
Synonyms
Glista ODGlimepirideAmaryl
Registration numbers
CAS Number
Properties
Pharmacology Properties
Target
DPP-4
Product Information
Salt Data
Free Base
Safety Information
Storage Condition
-20°C
Molecule Details
Research Area: Metabolic Disease
Biological Activity:
Glimepiride (Amaryl, Glista OD) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. [1] Glimepiride (Amaryl, Glista OD) is an oral blood-glucose-lowering agent of the sulfonylurea class. Like all sulfonylureas, glimepiride acts as a secretagogue. Glimepiride (Amaryl, Glista OD) lowers blood sugar by stimulating the release of insulin by pancreatic beta cells and by inducing increased activity of intracellular insulin receptors. [2]
Biological Activity:
Glimepiride (Amaryl, Glista OD) is a medium-to-long acting sulfonylurea anti-diabetic compound with an ED50 of 182 μg/kg. [1] Glimepiride (Amaryl, Glista OD) is an oral blood-glucose-lowering agent of the sulfonylurea class. Like all sulfonylureas, glimepiride acts as a secretagogue. Glimepiride (Amaryl, Glista OD) lowers blood sugar by stimulating the release of insulin by pancreatic beta cells and by inducing increased activity of intracellular insulin receptors. [2]
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data